# Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer

> **NCT02671045** · — · TERMINATED · sponsor: **Cota Inc.** · enrollment: 649 (actual)

## Conditions studied

- Carcinoma, Non-small Cell Lung

## Interventions

- **GENETIC:** Genomic profile by FoundationOne
- **GENETIC:** Genomic profile by other methods

## Key facts

- **NCT ID:** NCT02671045
- **Lead sponsor:** Cota Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 649 (ACTUAL)
- **Why stopped:** Insufficient accrual to Horizon Bluecross Blueshield cohort
- **Last updated:** 2018-07-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02671045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02671045, "Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02671045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*